Stephen Boyd Wiles - 31 Mar 2025 SCHEDULE 13G Report for Clearside Biomedical, Inc. Common Stock, $0.001 par value (CLSD)

Filing Manager: Stephen Boyd Wiles
Reporting Manager: Stephen Boyd Wiles
Security: Clearside Biomedical, Inc. Common Stock, $0.001 par value
Symbol: CLSD
Shares outstanding: 76,991,404 shares
Disclosed Ownership: 4,003,553 shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Filing time: 01 Apr 2025, 06:09:45 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Stephen Boyd Wiles	5.2%	4,003,553	4,003,553	0	/s/ Stephen Boyd Wiles	Stephen Boyd Wiles